{{Rsnum
|rsid=2290272
|Gene=SLC28A1
|Chromosome=15
|position=84904200
|Orientation=minus
|GMAF=0.3485
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SLC28A1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 36.3 | 52.2 | 11.5
| HCB | 28.7 | 51.5 | 19.9
| JPT | 45.5 | 42.0 | 12.5
| YRI | 69.2 | 28.1 | 2.7
| ASW | 50.9 | 49.1 | 0.0
| CHB | 28.7 | 51.5 | 19.9
| CHD | 34.3 | 50.9 | 14.8
| GIH | 16.8 | 61.4 | 21.8
| LWK | 64.5 | 30.0 | 5.5
| MEX | 20.7 | 53.4 | 25.9
| MKK | 70.5 | 26.3 | 3.2
| TSI | 49.5 | 44.6 | 5.9
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs2290272
|Name_s=SLC28A1: V189I
|Gene_s=SLC28A1
|Feature=Exon/NonSyn
|Evidence=PubMed ID:19940846
|Annotation=altered kinetics of gemcitabine in transfected cells
|Drugs=gemcitabine
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA165111581
}}

{{GET Evidence
|gene=SLC28A1
|aa_change=Val189Ile
|aa_change_short=V189I
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2290272
|overall_frequency_n=3263
|overall_frequency_d=10758
|overall_frequency=0.303309
|n_genomes=25
|n_genomes_annotated=0
|n_haplomes=28
|n_articles=1
|n_articles_annotated=1
|in_pharmgkb=Y
|nblosum100=-4
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}